William Larkins
Corporate Officer/Principal bei HIKMA PHARMACEUTICALS PLC
Profil
William C.
Larkins is currently the President-Injectables Business at Hikma Pharmaceuticals Plc.
Prior to his current position, he served as the Chief Executive Officer & Director at CUSTOpharm, Inc. Dr. Larkins holds a doctorate degree from The Ohio State University and an undergraduate degree from Purdue University.
Aktive Positionen von William Larkins
| Unternehmen | Position | Beginn |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.01.2022 |
Ehemalige bekannte Positionen von William Larkins
| Unternehmen | Position | Ende |
|---|---|---|
CUSTOpharm, Inc.
 CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Chief Executive Officer | 01.09.2022 |
Ausbildung von William Larkins
| The Ohio State University | Doctorate Degree |
| Purdue University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Health Technology |
